Goals

Develop supplements for the prevention and suppression of radiation-induced pulmonary fibrosis

Current Stage : Lead Compound and MOA Exploration Stage

- Research efficacy of ONCOBIX-owned compounds(in vivo, in vitro) - Examining the mechanism of action of ONCOBIX-owned compounds - Requires fibrosis pathogenesis target protein identification

Future Plan

- Hit compound discovery - MOA exploration and verification

Goals

Develop specific ALK/ROS1-positive NSCLC treatment

Current Stage : Lead/candidate compound exploration stage

- Document preparation for patent re-application - Efficacy studies in progress

Future Plan

- Patent re-application based on priority claims - Candidate compound for the first half decided, planned efficacy studies with the animal model

Goals

Develop FAK-targeted treatment for liver and pancreatic cancers

Current Stage : Lead compound exploration stage

- Initial compound delivery and evaluation completed - Drafting SAR, follow-up design suggested/span> - Initial evaluation result analysis, second delivery compound synthesis

Future Plan

- Hit compound discovery in the first half